The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological marker associated with the disease through a simple blood test. Apparently, that biological marker, which is found in spinal fluid, starts changing decades before the first signs of the disease show up. The problem is harvesting spinal fluid for testing is highly invasive and expensive, making it not ideal for an early detection procedure. What the IBM scientists have figured out is that it’s possible to identify the proteins in the blood that can predict the concentration of the biomarker in spinal fluid, making early detection not only possible but also affordable. The method is still in its early stages of testing, but in the future, scientists could use it to find appropriate subjects for programs developing a cure.
IBM is using machine learning to detect Alzheimer’s way before symptoms show up
More of Today's Solutions
AI to the rescue: how technology slashes stillbirths and saves lives in Malawi
BY THE OPTIMIST DAILY EDITORIAL TEAM When Ellen Kaphamtengo, 18, experienced intense stomach pain late in her pregnancy, she trusted her intuition. With her ...
Read MoreSave the spirit guardians: Hawaiian crows get a fresh start on Maui
BY THE OPTIMIST DAILY EDITORIAL TEAM For the first time in decades, five Hawaiian crows, or 'alalā, are soaring freely on the lush slopes ...
Read MoreSingapore’s Seletar airport considers plans for electric flying taxis
Seletar Airport is the city-state of Singapore’s lesser known second airport. It’s a small airfield normally frequented only by private jets, but soon it ...
Read MoreVent to your friends without bringing them down with these expert-approved tips
We've all had days when everything seemed to go wrong. Workplace drama or an argument with a loved one can really get us fired ...
Read More
